Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
复制标题
DOI:
10.1186/s12931-014-0157-3
复制
发表时间:
2014-12-12
影响因子:
5.8
通讯作者:
Roth M
中科院分区:
文献类型:
--
作者:
Hostettler KE;Zhong J;Papakonstantinou E;Karakiulakis G;Tamm M;Seidel P;Sun Q;Mandal J;Lardinois D;Lambers C;Roth M
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. The kinase inhibitor nintedanib specific for vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and fibroblast growth factor receptor (FGFR) significantly reduced the rate of decline of forced vital capacity versus placebo. To determine the in vitro effect of nintedanib on primary human lung fibroblasts. Methods: Fibroblasts were isolated from lungs of IPF patients and from non-fibrotic controls. We assessed the effect of VEGF, PDGF-BB and basic FGF (bFGF) ± nintedanib on: (i) expression/activation of VEGFR, PDGFR, and FGFR, (ii) cell proliferation, secretion of (iii) matrix metalloproteinases (MMP), (iv) tissue inhibitor of metalloproteinase (TIMP), and (v) collagen. IPF fibroblasts expressed higher levels of PDGFR and FGFR than controls. PDGF-BB, bFGF, and VEGF caused a pro-proliferative effect which was prevented by nintedanib. Nintedanib enhanced the expression of pro-MMP-2, and inhibited the expression of TIMP-2. Transforming growth factor-beta-induced secretion of collagens was inhibited by nintedanib. Our data demonstrate a significant anti-fibrotic effect of nintedanib in IPF fibroblasts. This effect consists of the drug’s anti-proliferative capacity, and on its effect on the extracellular matrix, the degradation of which seems to be enhanced.
登录
查看更多内容
DOI:
10.1165/ajrcmb.27.2.4674
发表时间:
2002-08-01
影响因子:
6.4
作者:
Kolb, M;Bonniaud, P;Gauldie, J
通讯作者:
Gauldie, J
DOI:
10.1164/rccm.2103112
发表时间:
2002-08-01
影响因子:
24.7
作者:
Koyama, S;Sato, E;Izumi, T
通讯作者:
Izumi, T
影响因子:
5
作者:
Hetzel, M;Bachem, M;Faehling, M
通讯作者:
Faehling, M
DOI:
10.1513/pats.201203-023aw
发表时间:
2012-07-01
期刊:
Proceedings of the American Thoracic Society
影响因子:
--
作者:
Fernandez, Isis E;Eickelberg, Oliver
通讯作者:
Eickelberg, Oliver
DOI:
10.1164/rccm.2009-040gl
发表时间:
2011-03-15
影响因子:
24.7
作者:
Raghu, Ganesh;Collard, Harold R.;Schuenemann, Holger J.
通讯作者:
Schuenemann, Holger J.